Release Date: December 20, 2024
Expiration Date: December 20, 2025
Activity Overview
This engaging interview with Dr Elias Jabbour highlights the evolving landscape of acute lymphoblastic leukemia (ALL) treatment, focusing on innovative strategies that are breaking barriers in care. Dr Jabbour provides insights into the integration of immunotherapy and CAR-T cell therapy, the role of newer generation TKIs, and the shift towards personalized and less chemotherapy-intensive approaches. Through real-world examples and data-driven discussions, the session emphasizes improving patient outcomes while addressing treatment safety, efficacy, and healthcare disparities.
Target Audience
This educational activity is directed toward physicians, nurses, NP/PAs, pharmacists, and other HCPs involved in the diagnosis and treatment of acute leukemias.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Examine the role of immunotherapy in frontline ALL treatment, focusing on patient selection and balancing benefits versus risks.
- Evaluate challenges in integrating CAR T-cell therapy into ALL care and its potential to replace transplants.
- Explore advancements in Ph-positive ALL, including novel agents, TKI selection, and emerging biomarkers.
Elias Jabbour, MD
Professor of Medicine
Department of Leukemia
Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center
Houston, TX
Disclosures: Grant/Research Support: AbbVie, Adaptive Biotechnologies, Amgen, Bristol Myers Squibb, Novartis Pharmaceuticals, Pfizer, Spectrum, Takeda Pharmaceutical Company.
Faculty, Staff, and Planners’ Disclosures
The staff of Physicians’ Education Resource®, LLC, have no relevant financial relationships with ineligible companies.
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here